Date Name Title Filing Type Shares Traded Price Total Held
Jun 29, 2012
Director, EVP CSO Pres REGN Res Lab
Director, EVP CSO Pres REGN Res Lab Form 4 Other acquisition or disposition -- -- 5,534
Jun 27, 2012
Director, EVP CSO Pres REGN Res Lab
Director, EVP CSO Pres REGN Res Lab Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 500,000 -- 1,333,041
May 02, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Other acquisition or disposition -- -- 5,534
Mar 27, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Other acquisition or disposition -- -- 5,534
Feb 16, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Other acquisition or disposition -- -- 5,534
Feb 15, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 129,902 -- 3,430
Feb 15, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 3,430 -- --
Feb 15, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,103 -- 10,103
Feb 15, 2012
Director, EVP CSO President Regeneron Re
Director, EVP CSO President Regeneron Re Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 266 -- 10,369
Jan 06, 2012
Director, EVP, CSO & Pres, REGN Res Labs
Director, EVP, CSO & Pres, REGN Res Labs Form 4 Other acquisition or disposition -- -- 5,390

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.